Você está no menu de acessibilidade

Utilize este identificador para citar ou criar um link para este item: http://acervodigital.unesp.br/handle/11449/68433
Título: 
Advances in prodrug design
Autor(es): 
Instituição: 
  • Universidade Estadual Paulista (UNESP)
  • Universidade de São Paulo (USP)
ISSN: 
1389-5575
Resumo: 
The background of prodrug design is presented herein as the basis for introducing new and advanced latent systems, taking into account mainly the versatility of polymers and other macromolecules as carriers. PDEPT (Polymer-Directed Enzyme Prodrug Therapy); PELT (Polymer-Enzyme Liposome Therapy); CDS (Chemical Delivery System); ADEPT(Antibody-Directed Enzyme Prodrug Therapy); GDEPT/VDEPT (Gene-Directed Enzyme Prodrug Therapy/Virus-Directed Enzyme Prodrug Therapy); ODDS (Osteotropic Drug Delivery System) and LEAPT (Lectin-directed enzyme-activated prodrug therapy) are briefly described and some examples are given. © 2005 Bentham Science Publishers Ltd.
Data de publicação: 
1-Out-2005
Citação: 
Mini-Reviews in Medicinal Chemistry, v. 5, n. 10, p. 893-914, 2005.
Duração: 
893-914
Palavras-chaves: 
  • Latent advanced systems
  • Macromolecules carriers
  • Prodrug design
  • Selective delivery systems
  • aminosalicylic acid
  • ampicillin
  • antiinflammatory agent
  • antileishmanial agent
  • antimalarial agent
  • antineoplastic agent
  • bisphosphonic acid derivative
  • cytochrome P450
  • diclofenac
  • doxorubicin
  • flucytosine
  • ibuprofen
  • irinotecan
  • isoniazid
  • ketoprofen
  • mevinolin
  • mitomycin
  • nitrofural
  • paclitaxel derivative
  • photosensitizing agent
  • prodrug
  • salazosulfapyridine
  • tacrolimus
  • testosterone derivative
  • tiaprofenic acid
  • tolmetin
  • trigonelline
  • tryptamine derivative
  • unindexed drug
  • antibody directed enzyme prodrug therapy
  • bactericidal activity
  • binding affinity
  • blood brain barrier
  • Chagas disease
  • diarrhea
  • drug absorption
  • drug activation
  • drug design
  • drug distribution
  • drug identification
  • drug receptor binding
  • drug screening
  • drug selectivity
  • drug stability
  • drug structure
  • drug synthesis
  • drug targeting
  • drug transformation
  • gastrointestinal toxicity
  • gene expression
  • human
  • hypercholesterolemia
  • in vivo study
  • macromolecule
  • malaria
  • minimum inhibitory concentration
  • nephrotoxicity
  • organoleptic property
  • osteoporosis
  • review
  • rheumatoid arthritis
  • structure activity relation
  • structure analysis
  • tuberculosis
  • ulcerative colitis
  • Animals
  • Antibodies
  • Drug Carriers
  • Drug Delivery Systems
  • Drug Design
  • Gene Therapy
  • Humans
  • Lectins
  • Macromolecular Substances
  • Osteoporosis
  • Prodrugs
  • Viruses
Fonte: 
http://dx.doi.org/10.2174/138955705774329528
Endereço permanente: 
Direitos de acesso: 
Acesso restrito
Tipo: 
outro
Fonte completa:
http://repositorio.unesp.br/handle/11449/68433
Aparece nas coleções:Artigos, TCCs, Teses e Dissertações da Unesp

Não há nenhum arquivo associado com este item.
 

Itens do Acervo digital da UNESP são protegidos por direitos autorais reservados a menos que seja expresso o contrário.